Pancreatic Cancer News and Research RSS Feed - Pancreatic Cancer News and Research

Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Low-dose chemotherapy regimens may be more effective at treating certain breast and pancreatic cancer types

Low-dose chemotherapy regimens may be more effective at treating certain breast and pancreatic cancer types

Conventional, high-dose chemotherapy treatments can cause the fibroblast cells surrounding tumors to secrete proteins that promote the tumors' recurrence in more aggressive forms, researchers at Taipei Medical University and the National Institute of Cancer Research in Taiwan and University of California, San Francisco, have discovered. [More]
Study uncovers mechanism that causes chemo resistance of pancreatic cancer cells

Study uncovers mechanism that causes chemo resistance of pancreatic cancer cells

A pioneering University of Liverpool research team have published a study that identifies the mechanism in the human body that causes resistance of pancreatic cancer cells to chemotherapy. [More]
New discovery may lead to better treatment options for pancreatic cancer patients

New discovery may lead to better treatment options for pancreatic cancer patients

Pancreatic cancer, the third leading cause of cancer-related deaths, is projected to be the second by the year 2030, according to a study in the journal of Cancer Research. [More]
Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

Weight loss condition provides clues to why cancer immunotherapy may fail in many patients

A weight loss condition that affects patients with cancer has provided clues as to why cancer immunotherapy - a new approach to treating cancer by boosting a patient's immune system -- may fail in a substantial number of patients. [More]
New research explains how tumors may impair ability of the liver to respond to caloric deprivation

New research explains how tumors may impair ability of the liver to respond to caloric deprivation

One of the worst cruelties of lethal cancer is the phenomenon called wasting, or in medical terms, cachexia (pronounced ka-CHEX-ia), in which a patient seems literally to diminish in bodily terms as the cancer ravages one or more internal organs. [More]
Targeted precision medicine can eliminate cancer risk in patients with Type 2 diabetes

Targeted precision medicine can eliminate cancer risk in patients with Type 2 diabetes

The links between Type 2 diabetes and cancer are complex: people suffering from diabetes mellitus essentially have a higher risk of developing cancer but, on top of that, some diabetes drugs are also suspected of increasing the risk in some cases. [More]
TGen study identifies potential new drug targets to alleviate pain in pancreatic cancer patients

TGen study identifies potential new drug targets to alleviate pain in pancreatic cancer patients

The Translational Genomics Research Institute has discovered potential drug targets to reduce pain in pancreatic cancer patients. [More]
Characteristics of brain tumour provide insight into survival, treatment options for patients over 70

Characteristics of brain tumour provide insight into survival, treatment options for patients over 70

Characteristics like seizures, location of the tumour, and pressure in the brain, give insight into length of survival and treatment options for brain tumour patients over the age of 70, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool. [More]
Group of circulating tumour cells in the blood linked to prostate cancer spread

Group of circulating tumour cells in the blood linked to prostate cancer spread

Researchers have found a group of circulating tumour cells in prostate cancer patient blood samples which are linked to the spread of the disease, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool. [More]
Pancreatic cancer to become third leading cause of death in the EU in 2017

Pancreatic cancer to become third leading cause of death in the EU in 2017

The number of deaths from pancreatic cancer will overtake breast cancer mortality rates in the EU in 2017, a study has found. [More]
Rearrangement of collagen linked to poor outcomes in pancreatic cancer patients

Rearrangement of collagen linked to poor outcomes in pancreatic cancer patients

A study in the current journal Oncotarget provides the first evidence linking a disturbance of the most common protein in the body with a poor outcome in pancreatic cancer. [More]
Researchers identify proteins in the blood that could improve detection of pancreatic cancer

Researchers identify proteins in the blood that could improve detection of pancreatic cancer

Pancreatic cancer is one of the most lethal forms of cancer because early stage symptoms are relatively light, often resulting in it being discovered only after spreading to other organs. In order to improve the prognosis of pancreatic cancer, the development of methods for early detection of pancreatic cancer with a blood test is important. [More]
Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

The National Institutes of Health has awarded two co-investigators at Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies. [More]
Research could lead to new type of treatment for pancreatic cancer based on gold nanoparticles

Research could lead to new type of treatment for pancreatic cancer based on gold nanoparticles

A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease. [More]
Scientists identify novel strategy to treat pancreatic cancer

Scientists identify novel strategy to treat pancreatic cancer

Researchers have found that a protein called SLC6A14 is overexpressed by several fold in pancreatic tumors taken from patients and in cancerous pancreatic cells lines compared with normal pancreatic tissue or normal pancreatic cells. [More]
NYU Langone's cancer researcher receives Outstanding Investigator Award from NCI

NYU Langone's cancer researcher receives Outstanding Investigator Award from NCI

Throughout her distinguished career, cancer researcher Dafna Bar-Sagi, PhD, has made fundamental contributions to the understanding of the mechanisms that drive the disease. [More]
TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

TUM scientists shed new light on metastases in the liver at early stage of pancreatic cancer

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected. [More]
TUM scientists discover molecular mechanism responsible for liver metastases at early stage

TUM scientists discover molecular mechanism responsible for liver metastases at early stage

Pancreatic cancer is an exceptionally aggressive type of cancer. Frequently, metastases already start to grow in other organs, particularly often in the liver, before the original tumor was even detected. [More]
HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Every 20 minutes, someone in the United States receives a cancer diagnosis related to human papillomavirus. HPV causes cancer of the cervix, anus and throat. [More]
Researchers discover new strategy to boost effectiveness of anti-cancer immune therapy

Researchers discover new strategy to boost effectiveness of anti-cancer immune therapy

Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. [More]
Advertisement